Opinions | Why Reinvent the Wheel When You Can Amplify the Effects of Existing Therapy Models?

In this Opinions piece, Clerkenwell Health’s Arda Ozcubukcu discusses the potential value that could be derived from a greater focus on the use of evidence-based psychotherapies in psychedelic research and practice. Below, Arda shares how such an approach may support efforts to prove cost-effectiveness, enable psychedelics to be more easily integrated into existing systems, and more.


The product has been added to your cart.

Continue shopping View Cart